能谱CT影像参数结合PIVKA-Ⅱ预测三阴性乳腺癌患者发生放疗抵抗的应用研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Application of energy spectrum CT image parameters combined with PIVKA Ⅱ to predict radiotherapy resistance in patients with triple-negative breast cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 基于能谱CT影像参数并结合维生素K缺乏或拮抗剂Ⅱ诱导蛋白(PIVKA-Ⅱ)预测三阴性乳腺癌患者发生放疗抵抗。方法 选取2022年12—2024年5月于本院就诊并进行放射治疗的80例三阴性乳腺癌患者,根据治疗效果分为抵抗组56例,有效组24例。并对其一般资料和能谱CT影像学特征分析。Logistic回归分析影响患者发生放疗抵抗的临床因素以及探讨能谱CT影像学参数和PIVKA-Ⅱ的关系。采用逻辑回归算法建立能谱CT影像学参数结合PIVKA-Ⅱ预测放疗抵抗模型,ROC曲线及AUC评价预测效能。〖HTH〗结果 两组在癌变位置、BMI、月经状态、吸烟史、饮酒史、高血压、糖尿病、初产年龄、家族病史、乳腺癌易感基因(BRCA)突变、淋巴结转移情况、手术类型、CEA、CA153等方面差异均无统计学意义(P>0.05),在年龄、病理分级、病程、长期服用避孕药或雌激素、PIVKA-Ⅱ方面有统计学差异(P<0.05)。能谱CT影像学特征参数中,两组患者的动脉期及静脉期k值、IC值、病灶长径、肿瘤边缘方面有统计学差异(P<0.05)。患者的年龄、病理分级、病程、长期服用避孕药或雌激素、PIVKA-Ⅱ浓度是发生放疗抵抗的危险影响因素(OR>1, P<0.05),变量之间相互独立,不存在多重共线性。调整年龄、病理分级、病程、长期服用避孕药或雌激素因素后,动脉期k 40~70keV、动脉期IC、静脉期k 40~70keV、静脉期IC和病灶长径与PIVKA-Ⅱ浓度存在相关性(P<0.05)。能谱CT影像学各参数结合PIVKA-Ⅱ均具有较好的预测价值,其中PIVKA-Ⅱ+动脉期k40~70keV+静脉期k40~70keV+动脉期IC+静脉期IC+病灶长径模型预测效能最高,AUC为0.855。结论 能谱CT影像参数结合PIVKA-Ⅱ对三阴性乳腺癌患者发生放疗抵抗具有较好的预测价值,PIVKA-Ⅱ+动脉期k40~70keV+静脉期k40~70keV+动脉期IC+静脉期IC+病灶长径模型预测效能最高

    Abstract:

    Objective To predict the radiation resistance in patients with triple-negative breast cancer based on spectral CT imaging parameters and combined with vitamin K deficiency or antagonist Ⅱ-induced protein (PIVKA-Ⅱ).Methods A total of 80 patients with triple-negative breast cancer who received radiotherapy in our hospital from May 2021 to May 2024 were selected and their general data and energy spectrum CT imaging characteristics were analyzed. Logistic regression was used to analyze the factors affecting the patients' radiotherapy resistance. Logistic regression was used to analyze the relationship between energy spectrum CT imaging parameters and PIVKA-Ⅱ. Logistic regression algorithm was used to establish the radiation resistance prediction model of energy spectrum CT imaging parameters combined with PIVKA-Ⅱ, ROC curve and AUC to evaluate the prediction efficiency. Results There were no significant differences between the two groups in cancer location, body mass index (BMI), menstrual status, hypertension, diabetes, smoking history, drinking history, age at first delivery, family history, BRCA mutation, lymph node metastasis, type of surgery, CEA, CA153, etc. (P>0.05). There were statistical differences in age, pathological grade, course of disease, long-term use of contraceptives or estrogen, PIVKA-Ⅱ (P<0.05). Among the characteristics of energy spectrum CT imaging parameters, there were statistical differences in k value (40~70keV) in arterial and venous phases, IC value in arterial and venous phases, focal diameter and tumor margin between the two groups (P<0.05). Age, pathological grade, course of disease, long-term use of contraceptives or estrogen, PIVKA-Ⅱ concentration were the risk factors for radiotherapy resistance (OR>1, P<0.05), and there was no multicollinearity among the variables. After adjusting for age, pathological grade, course of disease, long-term use of contraceptives or estrogen factors, there was a correlation between arterial k40 70keV, arterial IC, venous k 40-70kev,venous IC and focal length and PIVKA-Ⅱ concentration (P<0.05). All parameters of energy spectrum CT imaging combined with PIVKA-Ⅱ had good predictive value, among which PIVKA-Ⅱ+arterial phase k 40~70keV +venous phase k 40~70keV +arterial phase IC+venous phase IC+lesion length diameter (P4) had the highest predictive efficiency, and the AUC was 0.855. Conclusion Energy spectrum CT image parameters combined with PIVKA-Ⅱ has a good value in

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-01-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司